<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37277617</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-6692</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Herz</Title><ISOAbbreviation>Herz</ISOAbbreviation></Journal><ArticleTitle>Has COVID-19 changed the spectrum of arrhythmias and the incidence of sudden cardiac death?</ArticleTitle><Pagination><StartPage>212</StartPage><EndPage>217</EndPage><MedlinePgn>212-217</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00059-023-05186-2</ELocationID><Abstract><AbstractText>Arrhythmic manifestations of COVID-19 include atrial arrhythmias such as atrial fibrillation or atrial flutter, sinus node dysfunction, atrioventricular conduction abnormalities, ventricular tachyarrhythmias, sudden cardiac arrest, and cardiovascular dysautonomias including the so-called long COVID syndrome. Various pathophysiological mechanisms have been implicated, such as direct viral invasion, hypoxemia, local and systemic inflammation, changes in ion channel physiology, immune activation, and autonomic dysregulation. The development of atrial or ventricular arrhythmias in hospitalized COVID-19&#xa0;patients has been shown to portend a&#xa0;higher risk of in-hospital death. Management of these arrhythmias should be based on published evidence-based guidelines, with special consideration of the acuity of COVID-19 infection, concomitant use of antimicrobial and anti-inflammatory drugs, and the transient nature of some rhythm disorders. In view of new SARS-CoV&#x2011;2 variants that may evolve, the development and use of newer antiviral and immunomodulator drugs, and the increasing adoption of vaccination, clinicians must remain vigilant for other arrhythmic manifestations that may occur in association with this novel but potentially deadly disease.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuck</LastName><ForeName>Karl-Heinz</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Medizinische Klinik&#xa0;II - Kardiologie, Angiologie, Intensivmedizin,Universit&#xe4;tsklinikum Schleswig-Holstein, Campus L&#xfc;beck, Ratzeburger Allee&#xa0;160, 23538, L&#xfc;beck, Germany. karl-heinz.kuck@uksh.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LANS Cardio, Hamburg, Germany. karl-heinz.kuck@uksh.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schl&#xfc;ter</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>LANS Cardio, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vogler</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medizinische Klinik&#xa0;II - Kardiologie, Angiologie, Intensivmedizin,Universit&#xe4;tsklinikum Schleswig-Holstein, Campus L&#xfc;beck, Ratzeburger Allee&#xa0;160, 23538, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heeger</LastName><ForeName>Christian Hendrik</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Medizinische Klinik&#xa0;II - Kardiologie, Angiologie, Intensivmedizin,Universit&#xe4;tsklinikum Schleswig-Holstein, Campus L&#xfc;beck, Ratzeburger Allee&#xa0;160, 23538, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tilz</LastName><ForeName>Roland Richard</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Medizinische Klinik&#xa0;II - Kardiologie, Angiologie, Intensivmedizin,Universit&#xe4;tsklinikum Schleswig-Holstein, Campus L&#xfc;beck, Ratzeburger Allee&#xa0;160, 23538, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Hat COVID-19 das Spektrum der Herzrhythmusst&#xf6;rungen und die H&#xe4;ufigkeit des pl&#xf6;tzlichen Herztods ver&#xe4;ndert?</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Herz</MedlineTA><NlmUniqueID>7801231</NlmUniqueID><ISSNLinking>0340-9937</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016757" MajorTopicYN="N">Death, Sudden, Cardiac</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText>Zu den arrhythmischen Manifestationen von COVID-19 z&#xe4;hlen Vorhofarrhythmien wie Vorhofflimmern und Vorhofflattern, Fehlfunktionen des Sinusknotens, atrioventrikul&#xe4;re Leitungsst&#xf6;rungen, Kammer-Tachyarrhythmien, pl&#xf6;tzlicher Herzstillstand und kardiovaskul&#xe4;re Dysautonomien einschlie&#xdf;lich des &#x201e;Long-COVID-Syndroms&#x201c;. Verschiedene pathophysiologische Mechanismen wurden damit in Zusammenhang gebracht, wie etwa eine direkte virale Invasion, Hypox&#xe4;mie, lokale und systemische Entz&#xfc;ndung, &#xc4;nderungen in der Ionenkanal-Physiologie, Immunaktivierung oder autonome Fehlsteuerung. Es hat sich gezeigt, dass Vorhof- oder Kammerarrhythmien bei hospitalisierten COVID-19-Patienten auf eine erh&#xf6;hte Krankenhaussterblichkeit hinweisen. Die Behandlung dieser Arrhythmien sollte sich an evidenzbasierten Leitlinien orientieren, unter besonderer Ber&#xfc;cksichtigung des Ausma&#xdf;es der COVID-19-Infektion, des gleichzeitigen Einsatzes von antimikrobiellen und antientz&#xfc;ndlichen Medikamenten sowie des vor&#xfc;bergehenden Charakters mancher Rhythmusst&#xf6;rungen. Angesichts der m&#xf6;glichen Entstehung neuer SARS-CoV-2-Varianten, der Entwicklung und des Einsatzes neuer antiviraler und immunmodulatorischer Medikamente sowie der zunehmenden Verwendung von Impfstoffen ist es angezeigt, dass Kliniker aufmerksam auf andere arrhythmische Manifestationen achten, die m&#xf6;glicherweise im Zusammenhang mit dieser neuartigen, potenziell t&#xf6;dlichen Erkrankung auftreten.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Heart rhythm disorder</Keyword><Keyword MajorTopicYN="N">Pandemic</Keyword><Keyword MajorTopicYN="N">SARS-CoV&#x2011;2</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList><CoiStatement>K.-H.&#xa0;Kuck, M.&#xa0;Schl&#xfc;ter, J.&#xa0;Vogler, C.H.&#xa0;Heeger and R.R.&#xa0;Tilz declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>6</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>23</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37277617</ArticleId><ArticleId IdType="pmc">PMC10241132</ArticleId><ArticleId IdType="doi">10.1007/s00059-023-05186-2</ArticleId><ArticleId IdType="pii">10.1007/s00059-023-05186-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116:1666&#x2013;1687. doi: 10.1093/cvr/cvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng P, Zhu H, Witteles RM, et al. Cardiovascular risks in patients with COVID-19: potential mechanisms and areas of uncertainty. Curr Cardiol Rep. 2020;22:34. doi: 10.1007/s11886-020-01293-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-020-01293-2</ArticleId><ArticleId IdType="pmc">PMC7189178</ArticleId><ArticleId IdType="pubmed">32350632</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Zhang F, Xu M, et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol. 2003;52:715&#x2013;720. doi: 10.1099/jmm.0.05320-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.05320-0</ArticleId><ArticleId IdType="pubmed">12867568</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden D, Harrington R, Poppas A, et al. Considerations for drug interactions on QTc in exploratory COVID-19 treatment. Heart Rhythm. 2020;17:231&#x2013;232. doi: 10.1016/j.hrthm.2020.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.04.016</ArticleId><ArticleId IdType="pmc">PMC7194583</ArticleId><ArticleId IdType="pubmed">32302703</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a&#xa0;retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Rubio A, et al. Coronavirus disease 2019 and cardiac arrhythmias. Eur Cardiol. 2020;15:e66. doi: 10.15420/ecr.2020.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/ecr.2020.23</ArticleId><ArticleId IdType="pmc">PMC7689870</ArticleId><ArticleId IdType="pubmed">33294034</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopinathannair R, et al. COVID-19 and cardiac arrhythmias: a&#xa0;global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol. 2020;59:329&#x2013;336. doi: 10.1007/s10840-020-00789-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-020-00789-9</ArticleId><ArticleId IdType="pmc">PMC7268965</ArticleId><ArticleId IdType="pubmed">32494896</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, et al. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res. 2021;31:365&#x2013;368. doi: 10.1007/s10286-021-00798-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D, et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020;5:1281&#x2013;1285. doi: 10.1001/jamacardio.2020.3551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3551</ArticleId><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, et al. Clinical characteristics and outcomes of older patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: a&#xa0;single-centered, retrospective study. J Gerontol A Biol Sci Med Sci. 2020;75:1788&#x2013;1795. doi: 10.1093/gerona/glaa089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glaa089</ArticleId><ArticleId IdType="pmc">PMC7184388</ArticleId><ArticleId IdType="pubmed">32279081</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschauer HN, et al. Plasma concentrations of haloperidol and prolactin and clinical outcome in acutely psychotic patients. Pharmacopsychiatry. 1988;21:246&#x2013;251. doi: 10.1055/s-2007-1016964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-1016964</ArticleId><ArticleId IdType="pubmed">3227055</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu N, et al. Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a&#xa0;meta-analysis. int J Cardiol. 2013;169:62&#x2013;72. doi: 10.1016/j.ijcard.2013.08.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2013.08.078</ArticleId><ArticleId IdType="pubmed">24095158</ArticleId></ArticleIdList></Reference><Reference><Citation>Erg&#xfc;n B, et al. New-onset atrial fibrillation in critically ill patients with coronavirus disease 2019 (COVID-19) J Arrhythm. 2021;37:1196&#x2013;1204. doi: 10.1002/joa3.12619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/joa3.12619</ArticleId><ArticleId IdType="pmc">PMC8427018</ArticleId><ArticleId IdType="pubmed">34518774</ArticleId></ArticleIdList></Reference><Reference><Citation>Musikantow DR, et al. Atrial fibrillation in patients hospitalized with COVID-19: incidence, predictors, outcomes, and comparison to influenza. JACC Clin Electrophysiol. 2021;7:1120&#x2013;1130. doi: 10.1016/j.jacep.2021.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2021.02.009</ArticleId><ArticleId IdType="pmc">PMC7904279</ArticleId><ArticleId IdType="pubmed">33895107</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman JP, et al. Cardiac electrophysiology consultative experience at the epicenter of the COVID-19 pandemic in the United States. Indian Pacing Electrophysiol J. 2020;20:250&#x2013;256. doi: 10.1016/j.ipej.2020.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ipej.2020.08.006</ArticleId><ArticleId IdType="pmc">PMC7450949</ArticleId><ArticleId IdType="pubmed">32861812</ArticleId></ArticleIdList></Reference><Reference><Citation>Mountantonakis SE, et al. Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection. Heart Rhythm. 2021;18:501&#x2013;507. doi: 10.1016/j.hrthm.2021.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2021.01.018</ArticleId><ArticleId IdType="pmc">PMC7825902</ArticleId><ArticleId IdType="pubmed">33493650</ArticleId></ArticleIdList></Reference><Reference><Citation>Leentjens J, et al. COVID-19-associated coagulopathy and antithrombotic agents&#x2014;lessons after 1&#xa0;year. lancet Haematol. 2021;8:e524&#x2013;e533. doi: 10.1016/S2352-3026(21)00105-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(21)00105-8</ArticleId><ArticleId IdType="pmc">PMC8078884</ArticleId><ArticleId IdType="pubmed">33930350</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley TJ, et al. Large-vessel stroke as a&#xa0;presenting feature of COVID-19 in the young. n Engl J Med. 2020;382:e60. doi: 10.1056/NEJMc2009787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009787</ArticleId><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Rubio A, Dan GA. Cardiovascular pharmacotherapies focus: are low doses of direct-acting oral anticoagulants justified and appropriate in patients with nonvalvular atrial fibrillation? Eur Cardiol. 2016;11:115&#x2013;117. doi: 10.15420/ecr.2016:11.2:ED2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/ecr.2016:11.2:ED2</ArticleId><ArticleId IdType="pmc">PMC6159536</ArticleId><ArticleId IdType="pubmed">30310458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. Cardiac arrhythmias in patients with COVID-19. J Arrhythm. 2020;36:827&#x2013;836. doi: 10.1002/joa3.12405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/joa3.12405</ArticleId><ArticleId IdType="pmc">PMC7532267</ArticleId><ArticleId IdType="pubmed">33024460</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagher L, et al. High-degree atrioventricular block in COVID-19 hospitalized patients. Europace. 2021;23:451&#x2013;455. doi: 10.1093/europace/euaa333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euaa333</ArticleId><ArticleId IdType="pmc">PMC7928988</ArticleId><ArticleId IdType="pubmed">33432349</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu CM, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006;82:140&#x2013;144. doi: 10.1136/pgmj.2005.037515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.2005.037515</ArticleId><ArticleId IdType="pmc">PMC2596695</ArticleId><ArticleId IdType="pubmed">16461478</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinitz JS, et al. Bradyarrhythmias in patients with COVID-19: marker of poor prognosis? Pacing Clin Electrophysiol. 2020;43:1199&#x2013;1204. doi: 10.1111/pace.14042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.14042</ArticleId><ArticleId IdType="pmc">PMC7461386</ArticleId><ArticleId IdType="pubmed">32820823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira AJ, et al. The angiotensin-(1&#x2013;7)/Mas receptor axis is expressed in sinoatrial node cells of rats. j Histochem Cytochem. 2011;59:761&#x2013;768. doi: 10.1369/0022155411411712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/0022155411411712</ArticleId><ArticleId IdType="pmc">PMC3261602</ArticleId><ArticleId IdType="pubmed">21606202</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatla A, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17:1439&#x2013;1444. doi: 10.1016/j.hrthm.2020.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.06.016</ArticleId><ArticleId IdType="pmc">PMC7307518</ArticleId><ArticleId IdType="pubmed">32585191</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:811&#x2013;818. doi: 10.1001/jamacardio.2020.1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitacchione G, et al. Ventricular tachycardia storm management in a&#xa0;COVID-19&#xa0;patient: a&#xa0;case report. eur Heart J Case Rep. 2020;4(FI1):1&#x2013;6. doi: 10.1093/ehjcr/ytaa217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcr/ytaa217</ArticleId><ArticleId IdType="pmc">PMC7337657</ArticleId><ArticleId IdType="pubmed">33089046</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, et al. Effective treatment of severe COVID-19&#xa0;patients with tocilizumab. Proc Natl Acad Sci USA. 2020;117:10970&#x2013;10975. doi: 10.1073/pnas.2005615117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2005615117</ArticleId><ArticleId IdType="pmc">PMC7245089</ArticleId><ArticleId IdType="pubmed">32350134</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldi E, et al. Out-of-hospital cardiac arrest during the COVID-19 outbreak in Italy. n Engl J Med. 2020;383:496&#x2013;498. doi: 10.1056/NEJMc2010418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2010418</ArticleId><ArticleId IdType="pmc">PMC7204428</ArticleId><ArticleId IdType="pubmed">32348640</ArticleId></ArticleIdList></Reference><Reference><Citation>Marijon E, et al. Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a&#xa0;population-based, observational study. Lancet Public Health. 2020;5:e437&#x2013;e443. doi: 10.1016/S2468-2667(20)30117-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30117-1</ArticleId><ArticleId IdType="pmc">PMC7255168</ArticleId><ArticleId IdType="pubmed">32473113</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai PH, et al. Characteristics associated with out-of hospital cardiac arrests and resuscitations during the novel coronavirus disease 2019 pandemic in New York City. JAMA Cardiol. 2020;5:1154&#x2013;1163. doi: 10.1001/jamacardio.2020.2488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.2488</ArticleId><ArticleId IdType="pmc">PMC7305567</ArticleId><ArticleId IdType="pubmed">32558876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertini M, et al. Electrocardiographic features of 431&#xa0;consecutive, critically ill COVID-19&#xa0;patients: an insight into the mechanisms of cardiac involvement. Europace. 2020;22:1848&#x2013;1854. doi: 10.1093/europace/euaa258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euaa258</ArticleId><ArticleId IdType="pmc">PMC7543398</ArticleId><ArticleId IdType="pubmed">32944767</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarino A, Gennero L, Chen HC, et al. Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity. AIDS. 2001;15:2221&#x2013;2229. doi: 10.1097/00002030-200111230-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002030-200111230-00002</ArticleId><ArticleId IdType="pubmed">11698694</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Cao R, Xu M, et al. Hydroxychloroquine, a&#xa0;less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6:16. doi: 10.1038/s41421-020-0156-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-0156-0</ArticleId><ArticleId IdType="pmc">PMC7078228</ArticleId><ArticleId IdType="pubmed">32194981</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercuro NJ, Yen CF, Shim DJ, et al. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1036&#x2013;1041. doi: 10.1001/jamacardio.2020.1834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1834</ArticleId><ArticleId IdType="pmc">PMC7195692</ArticleId><ArticleId IdType="pubmed">32936252</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessi&#xe8;re F, Roccia H, Delini&#xe8;re A, et al. Assessment of QT intervals in a&#xa0;case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit. JAMA Cardiol. 2020;5:1067&#x2013;1069. doi: 10.1001/jamacardio.2020.1787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1787</ArticleId><ArticleId IdType="pmc">PMC7195693</ArticleId><ArticleId IdType="pubmed">32936266</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CC, Davies B, Gibbs K, et al. Multi-lead QT screening is necessary for QT measurement: implications for management of patients in the COVID-19 era. JACC Clin Electrophysiol. 2020;6:878&#x2013;880. doi: 10.1016/j.jacep.2020.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2020.04.001</ArticleId><ArticleId IdType="pmc">PMC7141442</ArticleId><ArticleId IdType="pubmed">32703574</ArticleId></ArticleIdList></Reference><Reference><Citation>Giudicessi JR, Roden DM, Wilde AA, Ackerman MJ. Genetic susceptibility for COVID-19-associated sudden cardiac death in African Americans. Heart Rhythm. 2020;17:1487&#x2013;1492. doi: 10.1016/j.hrthm.2020.04.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.04.045</ArticleId><ArticleId IdType="pmc">PMC7198426</ArticleId><ArticleId IdType="pubmed">32380288</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a&#xa0;report of 72 314&#xa0;cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidovich M. Transient Brugada-like electrocardiographic pattern in a&#xa0;patient with COVID-19. J Am Coll Cardiol Case Rep. 2020;2:1245&#x2013;1249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162623</ArticleId><ArticleId IdType="pubmed">32309815</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Aberer F, Braun M, Sourij H, Moser O. The arrhythmogenic face of COVID-19: Brugada ECG pattern in SARS-CoV-2 infection. J Cardiovasc Dev Dis. 2022;9:96. doi: 10.3390/jcdd9040096.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd9040096</ArticleId><ArticleId IdType="pmc">PMC9027624</ArticleId><ArticleId IdType="pubmed">35448072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorgente A, Capulzini L, Brugada P. The known into the unknown: Brugada syndrome and COVID-19. JACC Case Rep. 2020;2:1250&#x2013;1251. doi: 10.1016/j.jaccas.2020.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2020.04.006</ArticleId><ArticleId IdType="pmc">PMC7162640</ArticleId><ArticleId IdType="pubmed">32310242</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>